IP Library Granted Patent US 10,159,764
Granted Patent B2
US 10,159,764 · App. 15/496,297 · Granted Dec 25, 2018

Extracellular matrix sheet structures

Inventor: Robert G Matheny (Norcross, GA)
Assignee: Aziyo Med, LLC
A61L27/3629A61F2/0077A61F2/02A61L27/227A61L27/34A61L27/362A61L27/3604A61L27/3625A61L27/3633A61L27/38A61L27/3804A61L27/3834A61L27/50A61L27/54A61L31/005A61L31/041A61L31/14A61L31/16A61N1/375A61N1/3752A61F2/24A61F2002/0086A61F2210/0076A61K35/12A61K35/22A61K35/37A61K35/38A61K35/42A61K38/005A61K38/1825A61L27/3679A61L27/3683A61L2300/20A61L2300/23A61L2300/25A61L2300/252A61L2300/40A61L2300/404A61L2300/406A61L2300/41A61L2300/412A61L2300/414A61L2300/418A61L2300/434A61L2300/45A61L2300/64A61L2400/02A61L2400/12A61L2400/18A61L2430/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,159,764
App. No.
15/496,297
Granted
Dec 25, 2018
Kind
B2
Abstract

A sheet structure formed from an extracellular matrix (ECM) composition that includes acellular ECM derived from small intestine submucosa (SIS) tissue, gentamicin and vancomycin. The sheet structure is configured to modulate inflammation of damaged biological tissue and induce cell and tissue proliferation, bioremodeling of the damaged biological tissue, and regeneration of new tissue and tissue structures with site-specific structural and functional properties, when the tissue structure is delivered to the damaged biological tissue.

Claims (26)

1. An implantable medical product, comprising:

a bioremodelable pouch structure comprising an extracellular matrix (ECM) structure in sheet form, said ECM structure comprising acellular ECM material from a decellularized mammalian tissue source, said decellularized mammalian tissue source being small intestine submucosa (SIS), urinary bladder submucosa, stomach submucosa, epithelium of mesodermal origin, dermal extracellular matrix, subcutaneous extracellular matrix, gastrointestinal extracellular matrix, tissue surrounding growing bone, placental extracellular matrix, omentum extracellular matrix, cardiac extracellular matrix, kidney extracellular matrix, pancreas extracellular matrix, lung extracellular matrix, urinary basement membrane, liver basement membrane, or combinations thereof,

said pouch structure comprising an internal region or cavity and an opening, wherein the pouch structure is configured and sized to receive, encase and retain an electrical medical device therein and to allow such device to be inserted into the internal region or cavity of the pouch structure; with the pouch structure formed from either: (a) first and second ECM sheets, or (b) a single ECM sheet having first and second sheet portions, with each ECM sheet or sheet portion including at least three ECM layers having edges, wherein the edges of the ECM sheets or sheet portions are joined together by stitching or staples except for the edges that form the opening to provide the internal region or cavity between the sheets or sheet portions, wherein the edges forming the opening are configured for closing by stitching or stapling those edges after receiving the device;

wherein the pouch structure effectively improves biological functions by promoting tissue regeneration, modulated healing of adjacent tissue or growth of new tissue when implanted in a body of a warm blooded mammal.

2. The product of claim 1 , in combination with an electrical medical device wherein the internal region or cavity of the pouch structure contains the electrical medical device therein.

3. The product of claim 2 , wherein the medical device is a pacemaker, defibrillator, synthetic heart valve, ventricular assist device, artificial heart, physiological sensor, catheter, or an associated component thereof.

4. The product of claim 1 , wherein the internal region or cavity of the pouch structure contains a composition that is a pharmacological agent.

5. The product of claim 4 , wherein the pharmacological agent is or includes an antibiotic agent.

6. The product of claim 1 , wherein the pouch structure has a periphery that is round.

7. The product of claim 1 , wherein the pouch structure is generally rectangular.

8. The product of claim 7 , wherein the pouch structure includes the single ECM sheet that is folded to form one folded end of the pouch structure, wherein the edges of both sides of the first and second sheet portions adjacent the folded end are joined together to form closed sides with the opening located on the opposite side from the folded end, wherein the first and second ECM sheets or sheet portions have 4 layers of SIS material.

9. The product of claim 7 , wherein the pouch structure has first and second ECM sheets with the edges of the sheets joined together by stitching to form the pouch structure, wherein the first and second ECM sheets each have 4 layers of ECM material.

10. The product of claim 9 , in combination with an electrical medical device, wherein the internal region or cavity of the pouch structure contains the electrical medical device therein.

11. The product of claim 10 , wherein the electrical medical device is a pacemaker, defibrillator, synthetic heart valve, ventricular assist device, artificial heart, physiological sensor, catheter, or an associated component thereof.

12. The product of claim 10 , wherein the internal region or cavity of the pouch structure contains a composition that is a pharmacological agent.

13. The product of claim 11 , wherein the pharmacological agent is or includes an antibiotic agent.

14. The product of claim 10 , wherein the first and second ECM sheets each have 4 layers of SIS material.

15. The product of claim 14 , wherein the pouch structure has a plurality of holes in the first or second sheets or in both sheets.

16. The product of claim 1 , wherein the pouch structure has a plurality of holes in the sheets or sheet portions.

17. The product of claim 1 , wherein the first and second ECM sheets or sheet portions have 4 layers of ECM material.

18. The product of claim 1 , wherein the first and second ECM sheets or sheet portions have 4 layers of SIS material.

19. An implantable medical product, comprising:

a bioremodelable pouch structure comprising an extracellular matrix (ECM) structure in sheet form, said ECM structure comprising acellular ECM material from a decellularized mammalian tissue source, said decellularized mammalian tissue source being small intestine submucosa (SIS), urinary bladder submucosa, stomach submucosa, epithelium of mesodermal origin, dermal extracellular matrix, subcutaneous extracellular matrix, gastrointestinal extracellular matrix, tissue surrounding growing bone, placental extracellular matrix, omentum extracellular matrix, cardiac extracellular matrix, kidney extracellular matrix, pancreas extracellular matrix, lung extracellular matrix, urinary basement membrane, liver basement membrane, or combinations thereof,

said pouch structure comprising an internal region or cavity and an opening, wherein the pouch structure is configured and sized to receive, encase and retain an electrical medical device therein and to allow such device to be inserted into the internal region or cavity of the pouch structure; with the pouch structure formed from either: (a) first and second ECM sheets, or (b) a single ECM sheet having first and second sheet portions, with each ECM sheet or sheet portion including at least three ECM layers having edges, wherein the edges of the ECM sheets or sheet portions are joined together by stitching or staples except for the edges that form the opening to provide the internal region or cavity between the sheets or sheet portions, wherein the edges forming the opening are configured for closing by stitching those edges after receiving the device and the opening is closed by stitching or staples after inserting the device;

wherein the pouch structure effectively improves biological functions by promoting tissue regeneration, modulated healing of adjacent tissue or growth of new tissue when implanted in a body of a warm blooded mammal.

20. The product of claim 19 , wherein the electrical medical device is a pacemaker, defibrillator, synthetic heart valve, ventricular assist device, artificial heart, physiological sensor, catheter, or an associated component thereof and is enclosed within the pouch structure, with all edges of the pouch structure closed by stitches at small intervals with at least one lead conduit of the electrical medical device extending out of the pouch structure between the edges and stitching, wherein the first and second ECM sheets or sheet portions each have 4 layers of SIS material.

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Oct 3, 2025
From: SWK FUNDING LLC
To: ELUTIA INC. (F/K/A AZIYO BIOLOGICS, INC.); ELUTIA MED LLC (F/K/A AZIYO MED, LLC)
Reel/Frame 072468/0896 →
CHANGE OF NAME Recorded Sep 15, 2023
From: AZIYO BIOLOGICS, INC.
To: ELUTIA INC.
Reel/Frame 064923/0361 →
CHANGE OF NAME Recorded Sep 15, 2023
From: AZIYO MED, LLC
To: ELUTIA MED LLC
Reel/Frame 064923/0704 →
SECURITY INTEREST Recorded Aug 12, 2022
From: AZIYO BIOLOGICS, INC.; AZIYO MED, LLC
To: SWK FUNDING LLC
Reel/Frame 060792/0045 →
RELEASE OF SECURITY INTEREST Recorded Aug 12, 2022
From: AZIYO BIOLOGICS, INC.; AZIYO MED, LLC
To: MIDCAP FINANCIAL TRUST
Reel/Frame 061161/0001 →
RELEASE OF SECURITY INTEREST Recorded Aug 12, 2022
From: AZIYO BIOLOGICS, INC.; AZIYO MED, LLC
To: MIDCAP FUNDING IV TRUST
Reel/Frame 061164/0532 →
REAFFIRMATION & AMENDMENT TO SECURITY INTEREST (REVOLVING) Recorded Jul 24, 2019
From: AZIYO BIOLOGICS, INC.; AZIYO MED, LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 049842/0107 →
REAFFIRMATION & AMENDMENT TO SECURITY INTEREST (TERM) Recorded Jul 24, 2019
From: AZIYO BIOLOGICS, INC.; AZIYO MED, LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 049842/0132 →
SECURITY INTEREST (REVOLVING) Recorded Aug 2, 2017
From: AZIYO BIOLOGICS, INC.; AZIYO MED, LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 043414/0001 →
SEURITY INTEREST (TERM) Recorded Aug 2, 2017
From: AZIYO BIOLOGICS, INC.; AZIYO MED, LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 043413/0942 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2017
From: CORMATRIX CARDIOVASCULAR, INC.
To: AZIYO MED, LLC
Reel/Frame 042577/0126 →
Continuity (5)
Division 14685755 · Apr 14, 2015
Division 13896424 · May 17, 2013
Continuation In Part 13573566 · Sep 24, 2012
Continuation In Part 13328287 · Dec 16, 2011
Related Publication 20170304507A1 · Oct 26, 2017
Cited By (1)
US 12,514,958